Hi guys, this might be old news, but doing a bit of research today I came across this analysis by Edison Research of Destiny Pharma in the UK.
https://www.edisongroup.com/wp-content/uploads/2018/10/Destiny-Pharma-Destiny-beguiles-1.pdf
Destiny have just finished a Phase 2 trial (results Q1) of a drug similar to ours for prevention of post operative infections (yes i know, competition).
I found the analysis interesting because it gives some assumptions of potential earnings if all goes well.
Sorry if this has been posted before.
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-1441
-
- There are more pages in this discussion • 8,228 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
37.0¢ | 38.0¢ | 36.5¢ | $1.324M | 3.541M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4056 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 653729 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4056 | 0.370 |
3 | 139768 | 0.365 |
7 | 205337 | 0.360 |
2 | 94461 | 0.355 |
4 | 439000 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 649482 | 16 |
0.385 | 410186 | 6 |
0.390 | 352859 | 19 |
0.395 | 378120 | 10 |
0.400 | 866716 | 22 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online